353 related articles for article (PubMed ID: 15848609)
21. [Changes in calcium metabolism after kidney transplantation].
Berczi C; Asztalos L; Kincses Z; Országh I; Löcsey L; Balogh A; Balázs G
Magy Seb; 2001 Apr; 54(2):95-100. PubMed ID: 11339099
[TBL] [Abstract][Full Text] [Related]
22. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.
Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M
Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169
[TBL] [Abstract][Full Text] [Related]
23. Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation.
Yun YS; Kim BJ; Hong SP; Lee TW; Lim CG; Kim MJ
Transplant Proc; 1996 Jun; 28(3):1561-4. PubMed ID: 8658786
[No Abstract] [Full Text] [Related]
24. Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients.
Grotz WH; Mundinger FA; Rasenack J; Speidel L; Olschewski M; Exner VM; Schollmeyer PJ
Nephrol Dial Transplant; 1995 Nov; 10(11):2096-100. PubMed ID: 8643174
[TBL] [Abstract][Full Text] [Related]
25. Changes in bone mineral density following treatment of osteomalacia.
Bhambri R; Naik V; Malhotra N; Taneja S; Rastogi S; Ravishanker U; Mithal A
J Clin Densitom; 2006; 9(1):120-7. PubMed ID: 16731441
[TBL] [Abstract][Full Text] [Related]
26. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
[TBL] [Abstract][Full Text] [Related]
27. Bone mineral density improvement after successful parathyroidectomy in pre- and postmenopausal women with primary hyperparathyroidism: a prospective study.
Lumachi F; Camozzi V; Ermani M; DE Lotto F; Luisetto G
Ann N Y Acad Sci; 2007 Nov; 1117():357-61. PubMed ID: 17646261
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
29. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
[TBL] [Abstract][Full Text] [Related]
30. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V
Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
[TBL] [Abstract][Full Text] [Related]
31. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
Bai XL; Liang TB; Wu LH; Li DL; Geng L; Wang WL; Shen Y; Zhang M; Zheng SS
Transplant Proc; 2007 Dec; 39(10):3182-5. PubMed ID: 18089348
[TBL] [Abstract][Full Text] [Related]
32. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
33. Immunosuppressive agents and bone disease in renal transplant patients with hypercalcemia.
Sessa A; Esposito A; Iavicoli GD; Lettieri E; Dente G; Costa C; Bergallo M; Rossano R; Capuano M
Transplant Proc; 2010 May; 42(4):1148-55. PubMed ID: 20534247
[TBL] [Abstract][Full Text] [Related]
34. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
[TBL] [Abstract][Full Text] [Related]
35. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
36. Weekly risedronate in kidney transplant patients with osteopenia.
Torregrosa JV; Fuster D; Pedroso S; Diekmann F; Campistol JM; Rubí S; Oppenheimer F
Transpl Int; 2007 Aug; 20(8):708-11. PubMed ID: 17555530
[TBL] [Abstract][Full Text] [Related]
37. Development of lumbar bone mineral density in the late course after kidney transplantation.
Brandenburg VM; Ketteler M; Fassbender WJ; Heussen N; Freuding T; Floege J; Ittel TH
Am J Kidney Dis; 2002 Nov; 40(5):1066-74. PubMed ID: 12407653
[TBL] [Abstract][Full Text] [Related]
38. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
[TBL] [Abstract][Full Text] [Related]
39. Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function.
Akaberi S; Lindergård B; Simonsen O; Nyberg G
Transplantation; 2006 Sep; 82(6):749-52. PubMed ID: 17006320
[TBL] [Abstract][Full Text] [Related]
40. Hyperparathyroidism and vitamin D deficiency predispose to bone loss in renal transplant recipients.
Lim WH; Coates PS; Russ GR; Coates PT
Transplantation; 2009 Sep; 88(5):678-83. PubMed ID: 19741465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
